Sudan Loganathan
Stock Analyst at Stephens & Co.
(0)
# 4962
Out of 5,297 analysts
35
Total ratings
22.22%
Success rate
-32.21%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ELEV Elevation Oncology | Downgrades: Equal-Weight | 5 5 | 0.24 | 1983.33% | 4 | Mar 24, 2025 | |
IMNM Immunome | Reiterates: Overweight | 30 30 | 6.13 | 389.4% | 2 | Mar 20, 2025 | |
CPRX Catalyst Pharmaceuti... | Reiterates: Overweight | 33 33 | 23.39 | 41.09% | 2 | Feb 27, 2025 | |
ADCT ADC Therapeutics | Maintains: Overweight | 6 8 | 1.25 | 540% | 2 | Feb 24, 2025 | |
IDYA IDEAYA Biosciences | Reiterates: Overweight | 50 50 | 15 | 233.33% | 2 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 29 29 | 36.59 | -20.74% | 4 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 15 15 | 7.53 | 99.2% | 2 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 31 31 | 10.66 | 190.81% | 3 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 60 60 | 24.32 | 146.71% | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 140 140 | 87.22 | 60.51% | 2 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 1.38 | 262.32% | 2 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 4 | 1.4 | 185.71% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 55 | 6.83 | 705.27% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 0.96 | 1254.17% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 25 25 | 11.81 | 111.69% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 0.32 | 1462.5% | 2 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 20 | 1.55 | 1190.32% | 1 | May 14, 2024 |